Differentiation Dedifferentiation, and Transdifferentiation of BALB/c 3T3 T Mesenchymal Stem Cells: Potential Significance in Metaplasia and Neoplasia

Cancer Research

Volumn 46, Issue 10, 1986, Pages 5312-5319

  Sparks, Rodney L ^a   Seibel Ross, Elizabeth I ^a   Wier, Marjorie L ^a   Scot, Robert E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOCHEMISTRY; CYTOLOGY; ETIOLOGY; MESENCHYME CELL; METAPLASIA; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; HUMAN; MACROPHAGES; METAPLASIA; NEOPLASMS; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR STEM CELLS;

EID: 0022490421     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Burgess, A., and Nicola, N. Growth Factors and Stem Cells, pp. 1-18. New York: Academic Press, 1983.
2. Lotem, J., and Sachs, L. Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. Proc. Natl. Acad. Sci. USA, 79:4347-4351, 1982.
3. Mondal, S., and Heidelberger, C. Transformation of C3H/10T1/2 Cl8 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol ester. Nature (Lond.), 260: 710-711,1976.
4. Nakano, S., and Ts’o, P.O.P. Cellular differentiation and neoplasia: characterization of subpopulations of cells that have neoplasia-related growth properties in Syrian hamster embryo cell cultures. Proc. Natl. Acad. Sci. USA, 78:4995-4999, 1981.
5. Nakano, S., Ueo, H., Bruce, S.A., and Ts’o, P.O.P. A contact-insensitive subpopulation in Syrian hamster cell cultures with a greater susceptibility to chemically induced neoplastic transformation. Proc. Natl. Acad. Sci. USA, 82: 5005-5009, 1985.
6. Pierce, G.B., Shikes, R., and Fink, L.M. Cancer: A Problem of Developmental Biology, pp. 68-87. Englewood Cliffs, NJ: Prentice-Hall, 1978.
7. Scott, R.E., and Maercklein, P.B. An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: support for a concept that the initiation of carcinogenesis involves multiple phases. Proc. Natl. Acad. Sci. USA, 82: 2995-2999, 1985.
8. Yuspa, S.H., and Morgan, D.L. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature (Lond.), 295:72-74, 1981.
9. Craig, R.W., and Sager, R. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells. Proc. Natl. Acad. Sci. USA, 82:2062-2066, 1985.
10. Fibach, E., Landau, T., and Sachs, L. Normal differentiation of myeloid leukaemic cells induced by a differentiation-inducing protein. Nat. New Biol., 237:276-278, 1972.
11. Fibach, E., Peled, T., and Rachmilewitz, E.A. Self-renewal and commitment to differentiation of human leukemic promyelocytic cells (HL-60). J. Cell. Physiol., 113: 152-158, 1982.
12. Marks, P.A., Chen, Z., Banks, J., and Rifkind, R.A. Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division. Proc. Natl. Acad. Sci. USA, 80: 2281-2284,1983.
13. Peehl, D.M., and Stanbridge, E.J. The role of differentiation in the suppression of tumorigenicity in human cell hybrids. Int. J. Cancer, 30: 113-120, 1982.
14. Sachs, L. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc. Natl. Acad. Sci. USA, 77: 6152-6156, 1980.
15. Scott, R.E., and Florine, D.L. Cell cycle models for the aberrant coupling of growth arrest and differentiation in hyperplasia, metaplasia, and neoplasia. Am. J. Pathol., 107: 342-348, 1982.
16. Scott, R.E., Wille, J.J., Jr., Pittelkow, M.R., and Sparks, R.L. Biological mechanisms of stem cell carcinogenesis: a concept for multiple phases in the initiation of carcinogenesis and the role of differentiation control defects. In: J. C. Barrett and R. W. Tennant (eds.), Mammalian Cell Transformation, Mechanisms of Carcinogenesis, and Assays for Carcinogens, pp. 67-80. New York: Raven Press, 1985.
17. Scott, R.E., Wille, J.J., Jr., and Wier, M.L. Mechanisms for the initiation and promotion of carcinogenesis: a review and a new concept. Mayo Clin. Proc., 59:107-117, 1984.
18. Stanbridge, E.J., Der, C.J., Doersen, C-J., Nishimi, R.Y., Peehl, D.M., Weissman, B.E., and Wilkinson, S.E. Human cell hybrids: analysis of transformation and tumorigenicity. Science (Wash. DC), 215: 252-259, 1982.
19. Bruce, S.A., Brown, A.R., and Miller, P.S. New view of carcinogenesis: implications for chemotherapy and human risk assessment. In: J. C. Barrett and R. W. Tennant (eds.), Mammalian Cell Transformation: Mechanisms of Carcinogenesis and Assays for Carcinogens, pp. 105-121. New York: Raven Press, 1985.
20. Wille, J.J., Jr., Maercklein, P.B., and Scott, R.E. Neoplastic transformation and defective control of cell proliferation and differentiation. Cancer Res., 42: 5139-5146, 1982.
21. Wille, J.J., Jr., Pittelkow, M.R., and Scott, R.E. Normal and transformed human prokeratinocytes express divergent effects of a tumor promoter on cell cycle-mediated control of proliferation and differentiation. Carcinogenesis (Lond.), 6: 1181-1187,1985.
22. Yen, A. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation. Exp. Cell Res., 156:198-212, 1985.
23. Green, H., and Kehinde, O. Sublines of mouse 3T3 cells that accumulate lipid. Cell, 7: 113-116, 1974.
24. Harrison, J.J., Soudry, E., and Sager, R. Adipocyte conversion of CHEF cells in serum-free medium. J. Cell Biol., 100: 429-434, 1985.
25. Krawisz, B.R., Florine, D.L., and Scott, R.E. Differentiation of fibroblastlike cells into macrophages. Cancer Res., 41:2891-2899,1981.
26. Krawisz, B.R., and Scott, R.E. Coupling of proadipocyte growth arrest and differentiation. I. Induction by heparinized medium containing human plasma. J. Cell Biol., 94:394-399,1982.
27. Kuri-Harcuch, W., and Marsch-Moreno, M. DNA synthesis and cell division related to adipose differentiation of 3T3 cells. J. Cell. Physiol., 114:39-44, 1983.
28. Nixon, B.T., and Green, H. Growth hormone promotes the differentiation of myoblasts and preadipocytes generated by azacytidine treatment of IOTV2 cells. Proc. Natl. Acad. Sci. USA, 81:3429-3432, 1984.
29. Scott, R.E., Florine, D.L., Wille, J.J., Jr., and Yun, K. Coupling of growth arrest and differentiation at a distinct state in the Gi phase of the cell cycle Proc. Natl. Acad. Sci. USA, 79:845-849,1982.
30. Scott, R.E., Hoerl, B.J., Wille, J.J., Jr., Florine, D.L., Krawisz, B.R., and Yun, K. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation. J. Cell Biol., 94:400-405, 1982.
31. Campione-Piccardo, J., Craig, J., Sun, J-J., and McBumey, M.W. Commitment in a murine embryonal carcinoma cell line during differentiation induced by retinoic acid. Exp. Cell Res., 156:544-552, 1985.
32. Dean, A., Erard, F., Schneider, A.B., and Schechter, A.N. Induction of hemoglobin accumulation in human K562 cells by hemin is reversible. Science (Wash. DC), 212:459-461, 1981.
33. Devlin, B.H., and Konigsberg, I.R. Reentry into the cell cycle of differentiated skeletal myocytes. Dev. Biol., 95: 175-192, 1983.
34. Ebert, P.S., Wars, I., and Buell, D.N. Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors. Cancer Res., 36: 1809-1813,1976.
35. Gusella, J.F., Weil, S.C., Tsiftsoglou, A.S., Volloch, V., Neumann, J.R., Keys, C., and Housman, D.E. Hemin does not cause commitment of murine erythroleukemia (MEL) cells to terminal differentiation. Blood, 56: 481-487, 1980.
36. Hennings, H., Michael, D., Cheng, C., Steinert, P., Holbrook, K., and Yuspa, S.H. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell, 19:245-254,1980.
37. Leder, A., Orkin, S., and Leder, P. Differentiation of erythroleukemic cells in the presence of inhibitors of DNA synthesis. Science (Wash. DC), 190: 893-894, 1975.
38. Linkhart, T.A., Clegg, C.H., and Hauschka, S.D. Control of mouse myoblast commitment to terminal differentiation by mitogens. J. Supramol. Struct., 14:483-498, 1980.
39. Nadal-Ginard, B. Commitment, fusion, and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell, 15: 855-864, 1978.
40. Nguyen, H.T., Medford, R.M., and Nadal-Ginard, B. Reversibility of muscle differentiation in the absence of commitment: analysis of a myogenic cell line temperature-sensitive for commitment. Cell, 34:281-293,1983.
41. Pittelkow, M.R., Wille, J.J., Jr., and Scott, R.E. Two functionally distinct classes of growth arrest states in human prokeratinocytes that regulate clonogenic potential. J. Invest. Dermatol., 86: 410-417,1986.
42. Rovera, G., Olashaw, N., and Meo, P. Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis. Nature (Lond.), 284:69-70, 1980.
43. Wille, J.J., Jr., Pittelkow, M.R., Shipley, G.D., and Scott, R.E. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J. Cell. Physiol., 121: 31-44, 1984.
44. Nicola, N.A., Metcalf, D., Matsumoto, M., and Johnson, G.R. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells: identification as granulocyte colony-stimulating factor. J. Biol. Chem., 258: 9017-9023, 1983.
45. DiPaolo, J.A. Relative difficulties in transforming human and animal cells in vitro. J. Natl. Cancer Inst., 70:3-8, 1983.
46. Lechner, J.F., McClendon, I.A., LaVeck, M.A., Shamsuddin, A.M., and Harris, C.C. Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells. Cancer Res., 43: 5915-5921, 1983.
47. Hoerl, B.J., Wier, M.L., and Scott, R.E. Biological mechanisms for the loss of the differentiated phenotype by non–terminally differentiated adipocytes. Exp. Cell Res., 155: 422-434, 1984.
48. Wille, J.J., Jr., and Scott, R.E. Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the Gi phase of the cell cycle. J. Cell Physiol., 112: 115-122, 1982.
49. Diamond, L., O'Brien, T.G., and Rovera, G. Inhibition of adipose conversion of 3T3 fibroblasts by tumour promoters. Nature (Lond.), 269: 247-249, 1977.
50. Boone, C.W., and Scott, R.E. Plate–induced tumors of BALB/3T3 cells exhibiting foci of differentiation into pericytes, chondrocytes, and fibroblasts. J. Supramol. Struct., 14:233-240, 1980.
51. Chen, T.R. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res., 104:255-262, 1977.
52. Mann, K.G. Prothrombin. Methods Enzymol., 45: 123-156, 1976.
53. Wier, M.L., and Scott, R. E. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line. Cancer Res., 45:3339-3346,1985.
54. Li, C.Y., Yam, L. T., and Lam, K. W. Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J. Histochem. Cy–tochem., 75:473-481,1970.
55. McKean, D.J., Infante, A. J., Nilson, A., Kimoto, M., Fathman, C. G., Walker, E., and Warner, N. Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cell by B lymphocyte tumor cells. J. Exp. Med., 154: 1419-1431,1981.
56. Li, C.Y., Lam, K.W., and Yam, L.T. Esterases in human leukocytes. J. Histochem. Cytochem., 21: 1-12, 1973.
57. Yam, L.T., Li, C.Y., and Crosby, W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol., 55:283-290,1971.
58. Mizel, S.B. Interleukin 1 and T cell activation. Immunol. Rev., 63: 51-72, 1982.
59. Barrett, J.C., and Ts’o, P.O.P. Evidence for the progressive nature of neoplastic transformation in vitro. Proc. Natl. Acad. Sci. USA, 75: 3761-3765, 1978.
60. Milo, G.E., Jr., and DiPaolo, J. A. Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment. Nature (Lond.), 275:130-132, 1978.
61. Rheinwald, J.G., and Beckett, M.A. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell, 22: 629-632,1980.
62. Jariwalla, R.J., Aurelian, L., and Ts’o, P.O.P. Immortalization and neoplastic transformation of normal diploid cells by defined cloned DNA fragments of herpes simplex virus type Proc. Natl. Acad. Sci. USA, 80: 5902-5906,1983.
63. Land, H., Parada, L.F., and Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (Lond.), 304:596-602,1983.
64. Axelrad, A. A., McLeod, D. L., Suzuki, S., and Shreeve, M. M. Regulation of the population size of erythropoietic progenitor cells. Differentiation of normal and neoplastic hematopoietic stem cells. Cold Spring Harbor Conf. Cell Proliferation, 5: 155-163,1978.